세계의 유아 및 여성용 프로바이오틱스 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Probiotics for Infants and Women was estimated to be worth US$ 634 million in 2024 and is forecast to a readjusted size of US$ 1115 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Probiotics for Infants and Women cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In the 21st century, advances in technologies such as genetic sequencing have greatly accelerated gut microbiome research. As a result, our understanding of the health benefits and mechanisms of probiotics has become more comprehensive. Probiotics-live microorganisms that are generally recognized as beneficial to the host-have emerged as one of the most prominent applied categories in life sciences. For infants, probiotics help quickly establish and maintain a healthy gut microbiota. The two major families of probiotics are Lactobacillus and Bifidobacterium. While Lactobacillus functions similarly in both adults and infants, Bifidobacterium plays a particularly crucial role in early childhood. In women's health, probiotic research primarily focuses on preventing and treating vaginitis and improving health during pregnancy and postpartum. Today, probiotics attract significant attention across ordinary foods, health supplements, and pharmaceuticals. This report focuses on probiotic powder ingredients for infants and women.

The market for probiotics tailored to infants and women is currently experiencing rapid growth. Rising health awareness and increasing consumer preference for natural and functional products are driving demand. In the maternal and infant product categories, probiotics have become a key functional ingredient, commonly added to infant formula, complementary foods, and probiotic drops. In women's health, probiotics are increasingly used in dietary supplements aimed at improving reproductive health and regulating the gut microbiota. The probiotic raw powder segment, as a critical upstream component, has attracted strong attention from both domestic and international brands. Market players include traditional fermentation enterprises, biotech firms, and multinational health companies, contributing to an increasingly competitive landscape. With continued progress in basic research, accumulation of clinical evidence, and ongoing consumer education, the probiotics market for infants and women is expected to evolve toward greater specialization and precision. Future products will emphasize clearly defined probiotic strains supported by scientific validation. Personalized nutrition solutions and scenario-specific product designs will become major development directions. Regulatory frameworks will also become more rigorous, pushing the industry from a concept-driven to a standard- and evidence-based model. Moreover, innovative delivery systems (such as time-release capsules and smart microencapsulation) and combination formulations (such as synbiotics) will enhance product form and user experience. Key market drivers include the broader trend of upgraded health consumption, the rigid demand among specific groups such as infants and women, and the growing acceptance of microbiome science in both medical and wellness contexts. Ongoing innovation and sustained industry investment are also injecting momentum into the sector. However, the industry still faces significant challenges, such as inconsistent consumer understanding of probiotic benefits, lack of standardized strain efficacy data, variability in raw material quality, and issues with misleading marketing and regulatory gaps. These factors undermine product credibility and market penetration, posing obstacles to future growth.

This report aims to provide a comprehensive presentation of the global market for Probiotics for Infants and Women, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Probiotics for Infants and Women by region & country, by Type, and by Application.

The Probiotics for Infants and Women market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Probiotics for Infants and Women.

Market Segmentation

By Company

• DuPont
• Novonesis
• Lallemand
• BioGaia
• Probi
• Biosearch Life
• Morinaga Milk Industry
• Synbio Tech
• Kerry Group
• Nestle
• Yakult
• Sabinsa
• Evivo
• AB-Biotics
• Bioflag Group
• Beijing Scitop Bio-tech
• Hebei Yiran Biological Technology

Segment by Type

• Lactobacillus
• Bifidobacterium
• Others

Segment by Application

• Infant
• Women

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Probiotics for Infants and Women manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Probiotics for Infants and Women in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Probiotics for Infants and Women in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Probiotics for Infants and Women Product Introduction
• 1.2 Global Probiotics for Infants and Women Market Size Forecast
  • 1.2.1 Global Probiotics for Infants and Women Sales Value (2020-2031)
  • 1.2.2 Global Probiotics for Infants and Women Sales Volume (2020-2031)
  • 1.2.3 Global Probiotics for Infants and Women Sales Price (2020-2031)
• 1.3 Probiotics for Infants and Women Market Trends & Drivers
  • 1.3.1 Probiotics for Infants and Women Industry Trends
  • 1.3.2 Probiotics for Infants and Women Market Drivers & Opportunity
  • 1.3.3 Probiotics for Infants and Women Market Challenges
  • 1.3.4 Probiotics for Infants and Women Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Probiotics for Infants and Women Players Revenue Ranking (2024)
• 2.2 Global Probiotics for Infants and Women Revenue by Company (2020-2025)
• 2.3 Global Probiotics for Infants and Women Players Sales Volume Ranking (2024)
• 2.4 Global Probiotics for Infants and Women Sales Volume by Company Players (2020-2025)
• 2.5 Global Probiotics for Infants and Women Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Probiotics for Infants and Women Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Probiotics for Infants and Women Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Probiotics for Infants and Women
• 2.9 Probiotics for Infants and Women Market Competitive Analysis
  • 2.9.1 Probiotics for Infants and Women Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Probiotics for Infants and Women Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotics for Infants and Women as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Lactobacillus
  • 3.1.2 Bifidobacterium
  • 3.1.3 Others
• 3.2 Global Probiotics for Infants and Women Sales Value by Type
  • 3.2.1 Global Probiotics for Infants and Women Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Probiotics for Infants and Women Sales Value, by Type (2020-2031)
  • 3.2.3 Global Probiotics for Infants and Women Sales Value, by Type (%) (2020-2031)
• 3.3 Global Probiotics for Infants and Women Sales Volume by Type
  • 3.3.1 Global Probiotics for Infants and Women Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Probiotics for Infants and Women Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Probiotics for Infants and Women Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Probiotics for Infants and Women Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Infant
  • 4.1.2 Women
• 4.2 Global Probiotics for Infants and Women Sales Value by Application
  • 4.2.1 Global Probiotics for Infants and Women Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Probiotics for Infants and Women Sales Value, by Application (2020-2031)
  • 4.2.3 Global Probiotics for Infants and Women Sales Value, by Application (%) (2020-2031)
• 4.3 Global Probiotics for Infants and Women Sales Volume by Application
  • 4.3.1 Global Probiotics for Infants and Women Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Probiotics for Infants and Women Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Probiotics for Infants and Women Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Probiotics for Infants and Women Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Probiotics for Infants and Women Sales Value by Region
  • 5.1.1 Global Probiotics for Infants and Women Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Probiotics for Infants and Women Sales Value by Region (2020-2025)
  • 5.1.3 Global Probiotics for Infants and Women Sales Value by Region (2026-2031)
  • 5.1.4 Global Probiotics for Infants and Women Sales Value by Region (%), (2020-2031)
• 5.2 Global Probiotics for Infants and Women Sales Volume by Region
  • 5.2.1 Global Probiotics for Infants and Women Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Probiotics for Infants and Women Sales Volume by Region (2020-2025)
  • 5.2.3 Global Probiotics for Infants and Women Sales Volume by Region (2026-2031)
  • 5.2.4 Global Probiotics for Infants and Women Sales Volume by Region (%), (2020-2031)
• 5.3 Global Probiotics for Infants and Women Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Probiotics for Infants and Women Sales Value, 2020-2031
  • 5.4.2 North America Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Probiotics for Infants and Women Sales Value, 2020-2031
  • 5.5.2 Europe Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Probiotics for Infants and Women Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Probiotics for Infants and Women Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Probiotics for Infants and Women Sales Value, 2020-2031
  • 5.7.2 South America Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Probiotics for Infants and Women Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Probiotics for Infants and Women Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Probiotics for Infants and Women Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Probiotics for Infants and Women Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Probiotics for Infants and Women Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.3.2 United States Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.4.2 Europe Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.5.2 China Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.6.2 Japan Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.7.2 South Korea Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Probiotics for Infants and Women Sales Value, 2020-2031
  • 6.9.2 India Probiotics for Infants and Women Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Probiotics for Infants and Women Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 DuPont
  • 7.1.1 DuPont Company Information
  • 7.1.2 DuPont Introduction and Business Overview
  • 7.1.3 DuPont Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 DuPont Probiotics for Infants and Women Product Offerings
  • 7.1.5 DuPont Recent Development
• 7.2 Novonesis
  • 7.2.1 Novonesis Company Information
  • 7.2.2 Novonesis Introduction and Business Overview
  • 7.2.3 Novonesis Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Novonesis Probiotics for Infants and Women Product Offerings
  • 7.2.5 Novonesis Recent Development
• 7.3 Lallemand
  • 7.3.1 Lallemand Company Information
  • 7.3.2 Lallemand Introduction and Business Overview
  • 7.3.3 Lallemand Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Lallemand Probiotics for Infants and Women Product Offerings
  • 7.3.5 Lallemand Recent Development
• 7.4 BioGaia
  • 7.4.1 BioGaia Company Information
  • 7.4.2 BioGaia Introduction and Business Overview
  • 7.4.3 BioGaia Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 BioGaia Probiotics for Infants and Women Product Offerings
  • 7.4.5 BioGaia Recent Development
• 7.5 Probi
  • 7.5.1 Probi Company Information
  • 7.5.2 Probi Introduction and Business Overview
  • 7.5.3 Probi Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Probi Probiotics for Infants and Women Product Offerings
  • 7.5.5 Probi Recent Development
• 7.6 Biosearch Life
  • 7.6.1 Biosearch Life Company Information
  • 7.6.2 Biosearch Life Introduction and Business Overview
  • 7.6.3 Biosearch Life Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Biosearch Life Probiotics for Infants and Women Product Offerings
  • 7.6.5 Biosearch Life Recent Development
• 7.7 Morinaga Milk Industry
  • 7.7.1 Morinaga Milk Industry Company Information
  • 7.7.2 Morinaga Milk Industry Introduction and Business Overview
  • 7.7.3 Morinaga Milk Industry Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Morinaga Milk Industry Probiotics for Infants and Women Product Offerings
  • 7.7.5 Morinaga Milk Industry Recent Development
• 7.8 Synbio Tech
  • 7.8.1 Synbio Tech Company Information
  • 7.8.2 Synbio Tech Introduction and Business Overview
  • 7.8.3 Synbio Tech Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Synbio Tech Probiotics for Infants and Women Product Offerings
  • 7.8.5 Synbio Tech Recent Development
• 7.9 Kerry Group
  • 7.9.1 Kerry Group Company Information
  • 7.9.2 Kerry Group Introduction and Business Overview
  • 7.9.3 Kerry Group Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Kerry Group Probiotics for Infants and Women Product Offerings
  • 7.9.5 Kerry Group Recent Development
• 7.10 Nestle
  • 7.10.1 Nestle Company Information
  • 7.10.2 Nestle Introduction and Business Overview
  • 7.10.3 Nestle Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Nestle Probiotics for Infants and Women Product Offerings
  • 7.10.5 Nestle Recent Development
• 7.11 Yakult
  • 7.11.1 Yakult Company Information
  • 7.11.2 Yakult Introduction and Business Overview
  • 7.11.3 Yakult Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Yakult Probiotics for Infants and Women Product Offerings
  • 7.11.5 Yakult Recent Development
• 7.12 Sabinsa
  • 7.12.1 Sabinsa Company Information
  • 7.12.2 Sabinsa Introduction and Business Overview
  • 7.12.3 Sabinsa Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Sabinsa Probiotics for Infants and Women Product Offerings
  • 7.12.5 Sabinsa Recent Development
• 7.13 Evivo
  • 7.13.1 Evivo Company Information
  • 7.13.2 Evivo Introduction and Business Overview
  • 7.13.3 Evivo Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Evivo Probiotics for Infants and Women Product Offerings
  • 7.13.5 Evivo Recent Development
• 7.14 AB-Biotics
  • 7.14.1 AB-Biotics Company Information
  • 7.14.2 AB-Biotics Introduction and Business Overview
  • 7.14.3 AB-Biotics Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 AB-Biotics Probiotics for Infants and Women Product Offerings
  • 7.14.5 AB-Biotics Recent Development
• 7.15 Bioflag Group
  • 7.15.1 Bioflag Group Company Information
  • 7.15.2 Bioflag Group Introduction and Business Overview
  • 7.15.3 Bioflag Group Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Bioflag Group Probiotics for Infants and Women Product Offerings
  • 7.15.5 Bioflag Group Recent Development
• 7.16 Beijing Scitop Bio-tech
  • 7.16.1 Beijing Scitop Bio-tech Company Information
  • 7.16.2 Beijing Scitop Bio-tech Introduction and Business Overview
  • 7.16.3 Beijing Scitop Bio-tech Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Beijing Scitop Bio-tech Probiotics for Infants and Women Product Offerings
  • 7.16.5 Beijing Scitop Bio-tech Recent Development
• 7.17 Hebei Yiran Biological Technology
  • 7.17.1 Hebei Yiran Biological Technology Company Information
  • 7.17.2 Hebei Yiran Biological Technology Introduction and Business Overview
  • 7.17.3 Hebei Yiran Biological Technology Probiotics for Infants and Women Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Hebei Yiran Biological Technology Probiotics for Infants and Women Product Offerings
  • 7.17.5 Hebei Yiran Biological Technology Recent Development

8 Industry Chain Analysis

• 8.1 Probiotics for Infants and Women Industrial Chain
• 8.2 Probiotics for Infants and Women Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Probiotics for Infants and Women Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Probiotics for Infants and Women Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer